NCT06650189

Brief Summary

The goal of this prospective randomized clinical trial is to investigate the effect of music intervention on the stress of live born preterm neonates requiring admission to a Neonatal Intensive Care Unit, through the measurements of salivary biomarkers (hormones and proteins). The main question it aims to answer is: Can the daily music intervention reduce the stress levels created by the Neonatal Intensive Care Unit environment in preterm neonates? Researchers will compare preterm neonates who will not be exposed to music intervention to investigate potential discrepancies in salivary stress biomarkers. Participants will be exposed to recorded music for 5 consecutive days.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2024Jul 2026

Study Start

First participant enrolled

July 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2024

Completed
24 days until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

April 1, 2025

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

September 27, 2024

Last Update Submit

March 26, 2025

Conditions

Keywords

preterm neonatespremature neonatesstresssalivary biomarkersNICUpreterm infantspremature infantsmusic

Outcome Measures

Primary Outcomes (3)

  • Salivary stress biomarker 1 - Hormone

    Concentration of the hormone (Units: μg/dL).

    From enrollment to 5 consecutive days.

  • Salivary stress biomarker 2 - Enzyme

    Concentration of the enzyme (Units: U/L).

    From enrollment to 5 consecutive days.

  • Salivary stress biomarker 3 - Protein

    Concentration of the protein (Units: μg/mL).

    From enrollment to 5 consecutive days.

Secondary Outcomes (8)

  • Heart rate

    Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.

  • Respiratory rate

    Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.

  • Oxygen saturation

    Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.

  • Blood pressure

    Measured before, during, and after each music session daily. From enrollment to the end of intervention at 5 days.

  • Weight

    Measured daily, with cumulative weight gain assessed at the end of the 5 days.

  • +3 more secondary outcomes

Study Arms (2)

Standard of care

NO INTERVENTION

Preterm neonates will receive standard of care.

Music intervention

EXPERIMENTAL

Preterm neonates will be exposed to recorded music intervention. Recorded music will be played through a portable Bluetooth speaker (3.1 watt) placed in the incubator, which will be activated and controlled via a smartphone.

Other: Music intervention

Interventions

Recorded music created by a certified music therapist

Music intervention

Eligibility Criteria

Age28 Weeks - 37 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Born between 28 - 36+6 weeks of gestation
  • Absence of active infection including blood, urine, cerebrospinal fluid
  • Absence of congenital and genetic disorders and chromosomal abnormalities
  • Absence of nuclear jaundice
  • Absence of endocrine disorders
  • Absence of maternal use of illicit drugs prenatally
  • Non - sedated neonates
  • Positive bilateral transient evoked otoacoustic emissions
  • Stable clinical condition
  • Absence of brain injury

You may not qualify if:

  • Diagnosis of brain injury after the enrollment
  • Negative auditory brainstem response before discharge
  • Clinical deterioration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

General and Maternity Hospital of Athens Elena Venizelou

Athens, 11521, Greece

RECRUITING

Attikon General University Hospital

Chaïdári, 12462, Greece

NOT YET RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Dimitra Metallinou, Assistant Professor

CONTACT

Maria Tzeli, PhD candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 27, 2024

First Posted

October 21, 2024

Study Start

July 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

April 1, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

All collected de-identified individual participant data (IPD) may be shared upon reasonable request. Interested researchers may contact the Primary Investigator directly to request access. No external link or public repository will be provided.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 1 year after publication with no end date.
Access Criteria
Access to de-identified individual participant data (IPD) will be granted to qualified researchers upon reasonable request. Interested parties/research groups must submit a written proposal outlining the intended purpose, type of analysis to be conducted, and justification for access to the data. Data sharing will require the execution of a formal Data Sharing Agreement (DSA) to ensure data use is consistent with ethical and legal standards, including participant confidentiality and proper data handling. Requests will be reviewed by the Principal Investigator and/or a designated review panel. Evaluation will consider the scientific merit of the proposal, qualifications of the requesting researcher(s), and ethical considerations. Communication and submission of the proposal and signed DSA can be done via email to the Primary Investigator. Please contact the Primary Investigator directly for more information or to initiate a request.

Locations